“Designing of Heterocyclic Compounds As Promising VEGFR2 Tyrosine Kinase Inhibitors: An Insilico Analysis”. International Journal of Pharmaceutical Sciences and Drug Research, vol. 13, no. 6, Nov. 2021, pp. 685-98, https://doi.org/10.25004/IJPSDR.2021.130612.